TY - JOUR
T1 - Atypical response inhibition and error processing in 22q11.2 Deletion Syndrome and schizophrenia
T2 - Towards neuromarkers of disease progression and risk
AU - Francisco, Ana A.
AU - Horsthuis, Douwe J.
AU - Popiel, Maryann
AU - Foxe, John J.
AU - Molholm, Sophie
N1 - Funding Information:
We wish to thank Dr. Juliana Bates, who performed the clinical assessments, and Elise Taverna and Danielle Newbury for their help with data collection. We would also like to acknowledge the role of the Jacobi Medical Center and of the Montefiore-Einstein Regional Center for 22q11.2 Deletion Syndrome in recruitment, and the Rose F. Kennedy Intellectual and Developmental Disability Research Center for all of its support. We extend our most sincere gratitude to the participants and their families for their interest, their involvement, and their time. This work was supported in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under award number U54 HD090260.
Funding Information:
We wish to thank Dr. Juliana Bates, who performed the clinical assessments, and Elise Taverna and Danielle Newbury for their help with data collection. We would also like to acknowledge the role of the Jacobi Medical Center and of the Montefiore-Einstein Regional Center for 22q11.2 Deletion Syndrome in recruitment, and the Rose F. Kennedy Intellectual and Developmental Disability Research Center for all of its support. We extend our most sincere gratitude to the participants and their families for their interest, their involvement, and their time. This work was supported in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under award number U54 HD090260.
Publisher Copyright:
© 2020 The Author(s)
PY - 2020
Y1 - 2020
N2 - 22q11.2 deletion syndrome (also known as DiGeorge syndrome or velo-cardio-facial syndrome) is characterized by increased vulnerability to neuropsychiatric symptoms, with approximately 30% of individuals with the deletion going on to develop schizophrenia. Clinically, deficits in executive function have been noted in this population, but the underlying neural processes are not well understood. Using a Go/No-Go response inhibition task in conjunction with high-density electrophysiological recordings (EEG), we sought to investigate the behavioral and neural dynamics of inhibition of a prepotent response (a critical component of executive function) in individuals with 22q11.2DS with and without psychotic symptoms, when compared to individuals with idiopathic schizophrenia and age-matched neurotypical controls. Twenty-eight participants diagnosed with 22q11.2DS (14–35 years old; 14 with at least one psychotic symptom), 15 individuals diagnosed with schizophrenia (18–63 years old) and two neurotypical control groups (one age-matched to the 22q11.2DS sample, the other age-matched to the schizophrenia sample) participated in this study. Analyses focused on the N2 and P3 no-go responses and error-related negativity (Ne) and positivity (Pe). Atypical inhibitory processing was shown behaviorally and by significantly reduced P3, Ne, and Pe responses in 22q11.2DS and schizophrenia. Interestingly, whereas P3 was only reduced in the presence of psychotic symptoms, Ne and Pe were equally reduced in schizophrenia and 22q11.2DS, regardless of the presence of symptoms. We argue that while P3 may be a marker of disease severity, Ne and Pe might be candidate markers of risk.
AB - 22q11.2 deletion syndrome (also known as DiGeorge syndrome or velo-cardio-facial syndrome) is characterized by increased vulnerability to neuropsychiatric symptoms, with approximately 30% of individuals with the deletion going on to develop schizophrenia. Clinically, deficits in executive function have been noted in this population, but the underlying neural processes are not well understood. Using a Go/No-Go response inhibition task in conjunction with high-density electrophysiological recordings (EEG), we sought to investigate the behavioral and neural dynamics of inhibition of a prepotent response (a critical component of executive function) in individuals with 22q11.2DS with and without psychotic symptoms, when compared to individuals with idiopathic schizophrenia and age-matched neurotypical controls. Twenty-eight participants diagnosed with 22q11.2DS (14–35 years old; 14 with at least one psychotic symptom), 15 individuals diagnosed with schizophrenia (18–63 years old) and two neurotypical control groups (one age-matched to the 22q11.2DS sample, the other age-matched to the schizophrenia sample) participated in this study. Analyses focused on the N2 and P3 no-go responses and error-related negativity (Ne) and positivity (Pe). Atypical inhibitory processing was shown behaviorally and by significantly reduced P3, Ne, and Pe responses in 22q11.2DS and schizophrenia. Interestingly, whereas P3 was only reduced in the presence of psychotic symptoms, Ne and Pe were equally reduced in schizophrenia and 22q11.2DS, regardless of the presence of symptoms. We argue that while P3 may be a marker of disease severity, Ne and Pe might be candidate markers of risk.
KW - EEG
KW - Go/No-Go
KW - Ne
KW - P3
KW - Pe
KW - Psychosis
KW - Visual event-related potentials
UR - http://www.scopus.com/inward/record.url?scp=85088651545&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088651545&partnerID=8YFLogxK
U2 - 10.1016/j.nicl.2020.102351
DO - 10.1016/j.nicl.2020.102351
M3 - Article
C2 - 32731196
AN - SCOPUS:85088651545
SN - 2213-1582
VL - 27
JO - NeuroImage: Clinical
JF - NeuroImage: Clinical
M1 - 102351
ER -